Effect of age on the outcome of angioplasty for acute myocardial infarction among patients treated at the Mayo Clinic

American Journal of Medicine

Volumn 108, Issue 3, 2000, Pages 187-192

  Singh, Mandeep ^a   Mathew, Verghese ^a   Garratt, Kirk N ^a   Berger, Peter B ^a   Grill, Diane E ^a   Bell, Malcolm R ^a   Rihal, Charanjit S ^a   Holmes Jr , David R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; STREPTOKINASE;

ACUTE HEART INFARCTION; AGED; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0033969502     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00429-5     Document Type: Article

References (18)

1. Graves EJ. National Hospital Discharge Survey. Vital Health Stat 13. 1993;114:28-29.
2. Simes RJ, Topol EJ, Holmes DR Jr, et al, for the GUSTO-I Investigators. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. Circulation. 1995;91:1923-1928.
3. AIMS Trial Study Group. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet. 1988;1:545-549.
4. Wilcox RG, von der Lippe G, Olsson CG, et al, for the ASSET Study Group. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet. 1988;2:525-530.
5. Franzosi MG, Santoro E, De Vita C, et al, on behalf of the GISSI Investigators. Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-1 study. Circulation. 1998;98:2659-2665.
6. Grines CL, Browne KF, Marco J, et al, for the Primary Angioplasty in Myocardial Infarction Study Group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. NEJM. 1993;328:673-679.
7. Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA. 1997; 278:2093-2098.
8. Therneau T, Sicks J, Bergstralh E, Offord J. Expected survival based on hazard rates. Rochester, Minn: Mayo Clinic, Section of Biostatistics, Technical Report Series No. 52, March 1994.
9. Thompson RC, Holmes DR Jr, Gersh BJ, et al. Percutaneous transluminal coronary angioplasty in the elderly: early and long-term results. J Am Coll Cardiol. 1991;17:1245-1250.
10. Nakagawa Y, Shizuta S, Tamura T. Direct angioplasty for acute myocardial infarction in elderly patients (≥80-year-old). Circulation. 1997;96(suppl 1):I-397. Abstract.
11. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. NEJM. 1993;329:673-682.
12. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2:349-360.
13. Gurwitz JH, Gore JM, Goldberg RJ, et al. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction. National Registry of Myocardial Infarction. Ann Intern Med. 1996;124:283-291.
14. Zijlstra F, de Boer MJ, Hoorntje JC, et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. NEJM. 1993;328:680-684.
15. Ribeiro EE, Silva LA, Carneiro R, et al. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol. 1993;22:376-380.
16. Holland KJ, O'Neill WW, Bates ER, et al. Emergency percutaneous transluminal coronary angioplasty during acute myocardial infarction for patients more than 70 years of age. Am J Cardiol. 1989;63: 399-403.
17. Lee TC, Laramee LA, Rutherford BD, et al. Emergency percutaneous transluminal coronary angioplasty for acute myocardial infarction in patients 70 years of age and older. Am J Cardiol. 1990;66: 663-667.
18. Holmes DR Jr, White HD, Pieper KS, et al. Effect of age on outcome with primary angioplasty versus thrombolysis. J Am Coll Cardiol. 1999;33:412-419.